AirSculpt Technologies, Inc. Commences Roadshow for Proposed Initial Public Offering
AirSculpt Technologies has announced the commencement of its initial public offering (IPO) roadshow, aiming to raise funds by offering 1,562,500 shares of common stock, alongside 8,437,500 shares from existing stockholders. The IPO price is set between $15.00 and $17.00 per share, with an option for underwriters to purchase up to 1,500,000 additional shares. The company intends to list its stock on Nasdaq under the symbol 'AIRS'. Morgan Stanley and Piper Sandler are leading the offering, with a registration statement already filed with the SEC but not yet effective.
- Offering of 1,562,500 shares may generate significant capital.
- Potential for additional funding through underwriter's option to purchase 1,500,000 shares.
- Dilution risk for existing shareholders due to large volume of shares being offered.
- Registration statement not yet effective, delaying the sale of securities.
MIAMI BEACH, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”), an industry leader and national provider of body contouring procedures delivering a premium consumer experience under its brand, Elite Body Sculpture, today announced it has commenced the roadshow for the initial public offering of its common stock, pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission ("SEC"). AirSculpt is offering 1,562,500 shares of common stock, and certain existing stockholders are offering 8,437,500 shares of common stock, plus up to an additional 1,500,000 shares that the underwriters have an option to purchase.
The initial public offering price is currently expected to be between
AirSculpt intends to list its common stock on The Nasdaq Stock Market under the symbol "AIRS".
Morgan Stanley, Piper Sandler & Co. and SVB Leerink LLC are acting as lead book-running managers for the proposed offering. First Liberties Financial and Raymond James are acting as co-managers. The offering is being made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained from the SEC at www.sec.gov, and from: Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014. Attention: Prospectus Department; Piper Sandler & Co., 800 Nicollet Mall, J12S03, Minneapolis, MN 55402. Attention: Prospectus Department; SVB Leerink LLC, 53 State Street, 40th Floor, Boston, MA 02109. Attention: Syndicate Department.
A registration statement on Form S-1 relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About AirSculpt Technologies, Inc.
AirSculpt is an experienced, fast-growing national provider of body contouring procedures delivering a premium consumer experience. At Elite Body Sculpture, we provide custom body contouring using our proprietary AirSculpt® method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. It is our mission to generate the best results for our patients.
For Investor Relations Contact:
Dennis Dean
investors@elitebodysculpture.com
FAQ
What is the expected IPO price for AirSculpt Technologies?
How many shares is AirSculpt Technologies offering in its initial public offering?
When will AirSculpt Technologies list its stock on Nasdaq?
Who are the lead managers for AirSculpt's IPO?
Is the registration statement for AirSculpt's IPO effective?
